A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice

Human metapneumovirus (HMPV) and human respiratory virus (HRSV) are two leading causes of acute respiratory tract infection in young children. While there is no licensed drug against HMPV, the monoclonal antibody (mAb) Palivizumab is approved against HRSV for prophylaxis use only. Novel therapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Fausther-Bovendo, Hugues, Hamelin, Marie-Eve, Carbonneau, Julie, Venable, Marie-Christine, Checkmahomed, Liva, Lavoie, Pierre-Olivier, Ouellet, Marie-Ève, Boivin, Guy, D’Aoust, Marc-André, Kobinger, Gary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599547/
https://www.ncbi.nlm.nih.gov/pubmed/36289776
http://dx.doi.org/10.3390/biomedicines10102516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599547/
https://www.ncbi.nlm.nih.gov/pubmed/36289776
http://dx.doi.org/10.3390/biomedicines10102516

Ejemplares similares